Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
05-21 | Manzo Pharmaceuticals, Inc. announced that it expects to receive $0.0005 million in funding | CI |
2015 | Manzo Pharmaceuticals Inc. Announces New Product Somnaid Release | CI |
Business Summary
Number of employees: 12
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - |
Company contact information
Manzo Pharmaceuticals, Inc.
6153 Main Street Suite 2
L4A 3R6, Stouffville
+
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.1K | |
+15.54% | 78.51B | |
+12.05% | 9B | |
+58.17% | 4.96B | |
-14.94% | 4.84B | |
-.--% | 3.72B | |
+21.94% | 2.48B | |
-26.63% | 2.19B | |
+16.75% | 2.12B | |
-37.97% | 1.94B |
- Stock Market
- Equities
- MNZO Stock
- Company Manzo Pharmaceuticals, Inc.